Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

NDTDI

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
NDTDI
Clinical data
Other namesN-(2-Diethylcarbamoylethyl)-N-methyl-4,α-methylenetryptamine;N-(3-Diethylamino-3-oxopropyl)-N-methyl-4,α-methylenetryptamine; 8,10-Seco-LSD
Drug classSimplified/partial LSD analogue
ATC code
  • None
Legal status
Legal status
  • Illegal in Latvia
Identifiers
  • N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
PubChemCID
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC19H27N3O
Molar mass313.445 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23
  • InChI=1S/C19H27N3O/c1-4-22(5-2)18(23)9-10-21(3)16-11-14-7-6-8-17-19(14)15(12-16)13-20-17/h6-8,13,16,20H,4-5,9-12H2,1-3H3
  • Key:JECGWOMOCPQHDH-UHFFFAOYSA-N

NDTDI, also known as8,10-seco-LSD, is atricyclictryptaminederivative which is thought to act as aserotonin receptoragonist, though itspharmacology has not been studied in detail.[1] It is astructurallysimplifiedanalogue of thepsychedelic druglysergic acid diethylamide (LSD) and is reported to retain similar effects, though with many times lowerpotency.[1] NDTDI is specifically the analogue of LSD in which the carbon atom at position 9 of theergolinering system has been removed.[1] It has been sold as adesigner drug since 2016 and was first identified by aforensiclaboratory inSlovenia in 2017.[2] NDTDI was made illegal inLatvia in March 2017.[3]

The simplified analogue of NDTDI and LSD in which the carbons at positions 9 and 10 of the ergoline ring system have been removed, resulting in a fully non-rigid tryptamine derivative, isN-DEAOP-NMT.[4][5]

LSD (left), NDTDI (center), andN-DEAOP-NMT (right)chemical structures.

See also

[edit]

References

[edit]
  1. ^abc"N,N-Diethyl-N3-methyl-N3-(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)-I(2)-alaninamide".PubChem. Retrieved20 March 2025.
  2. ^Analytical Report NDTDI (C19H27N3O) 3-({2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,8(12),9-tetraen-6-yl}(methyl)amino)-N,N-diethylpropanamide(PDF), European Project Response
  3. ^Autorizēties savā kontā (March 2017)."Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem" [On the prohibition of the substance NDTDI and products containing it].LIKUMI.LV (in Latvian). Retrieved20 March 2025.
  4. ^Nichols DE (May 1973).Potential Psychotomimetics: Bromomethoxyamphetamines and Structural Congeners of Lysergic Acid (Thesis).University of Iowa. p. 23.OCLC 1194694085.Sklar, et al. (53) found the diethylacrylamide adduct 20 to be approximately 1/10 as active as LSD in mice, although Norris and Blicke (54) reported 21 to have little oxytocic activity. [...] 20 = R = C2H5. 21 = R = CH3 [...]
  5. ^Norris PE, Blicke FF (December 1952). "Potential ergot substitutes: esters and amides of beta-amino acids".J Am Pharm Assoc Am Pharm Assoc.41 (12):637–639.doi:10.1002/jps.3030411204.PMID 13022416.Six esters and amides of derivatives of β-alanine which are related to lysergic acid have been prepared and tested for oxytocic activity. None of these products possess a significant oxytocic activity. [...] The purpose of this investigation was to synthesize amides and also esters of compounds (II–V) which represent fragments of the lysergic acid molecule in the hope that some of these products might possess oxytocic activity. Various modified fragments of the lysergic acid molecule have been synthesized previously; it was claimed that some of the compounds are active oxytocics (1—7). [...] Pharmacologic data indicated that none of the esters or amides of compounds II—V which were prepared possess a significant oxytocic action when compared to the clinically used oxytocics. However, the diethylamide of N-methyl-N-[β′-(3-indolyl)-ethyl]-β-alanine (IIIc) appeared to have an oxytocic activity approximately ten times stronger than that of the diethylamide of N-methyl-N-(β′-phenethyl)-β-alanine (IIc).

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Retrieved from "https://en.wikipedia.org/w/index.php?title=NDTDI&oldid=1318139236"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp